Clinical trial
A Study to Learn More About How Safe Dienogest is and How Well it Works Under…
NCT04808843 · Bayer, Industry · Completed
Key facts
| NCT number | NCT04808843 |
|---|---|
| Title | A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis |
| Official title | Phase IV Study to Assess the Safety and Effectiveness of Dienogest (Visanne®) Amongst Indian Women With Endometriosis, in Real-world Clinical Practice: the VISAGE Study |
| Acronym | VISAGE |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Endometriosis Associated Pelvic Pain |
| Intervention type | Drug |
| Interventions | Dienogest (BAY86-5258, Visanne) |
| Enrollment | 160 |
| Start date | May 13, 2022 |
| Primary completion | Feb 5, 2024 |
| Completion | Sep 23, 2024 |
| First posted | Mar 22, 2021 |
| Last update posted | Jan 22, 2025 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: